Recruiting OBSERVATIONAL NCT06194968

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study (TASK-UK)

Sponsor: Techpool Bio-Pharma Co., Ltd.

Conditions Acute Ischemic Stroke

Interventions Alteplase Urokinase

Updated 3 times since 2024 Last updated: Dec 22, 2023 Started: Dec 30, 2023 Primary completion: Nov 1, 2025 Completion: Dec 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Ischemic Stroke, this trial is actively recruiting participants. The trial is conducted by Techpool Bio-Pharma Co., Ltd. and has accumulated 3 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Feb 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Dec 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Techpool Bio-Pharma Co., Ltd.
The First Affiliated Hospital of Zhengzhou University

Data source: The First Affiliated Hospital of Zhengzhou University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anyang, China , Beiliu, China , Guidong, China , Jiamusi, China , Kaifeng, China , Lanzhou, China , Luoyang, China , Pingdingshan, China , Sanya, China , Tongliao, China and 4 more locations